INSPECS Group plc (AIM:SPEC)
45.50
-1.00 (-2.15%)
Oct 10, 2025, 5:07 PM GMT+1
INSPECS Group Revenue
INSPECS Group had revenue of 97.62M GBP in the half year ending June 30, 2025, a decrease of -12.21%. This brings the company's revenue in the last twelve months to 195.28M, up 1.34% year-over-year. In the year 2024, INSPECS Group had annual revenue of 198.26M, down -2.48%.
Revenue (ttm)
195.28M
Revenue Growth
+1.34%
P/S Ratio
0.24
Revenue / Employee
118.06K
Employees
1,654
Market Cap
46.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 198.26M | -5.03M | -2.48% |
Dec 31, 2023 | 203.29M | 2.34M | 1.16% |
Dec 31, 2022 | 200.96M | 18.93M | 10.40% |
Dec 31, 2021 | 182.02M | 147.30M | 424.13% |
Dec 31, 2020 | 34.73M | -11.52M | -24.90% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |